# Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study)

> **NCT02376881** · PHASE3 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 24 (estimated)

## Conditions studied

- Optic Nerve Diseases

## Interventions

- **DRUG:** Erythropoietin
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02376881
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03
- **Primary completion:** 2019-03-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02376881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02376881, "Erythropoietin in Methanol Associated Optic Neuropathy: A Phase-2 Clinical Trial (EPO-MAON Study)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02376881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*